JPRN-jRCT2080220729未知3 期
ZO-Y49 PhaseIII clinical trial
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •Out patients who can understand the content of this trial and from whom a written informed consent to participate in this study can be directly obtained.
- •In addition, in the case of patients whose age is less than 20 years old when the informed consent is obtained, the patients from whose representative a written informed consent must be obtained too.
排除标准
- 未提供
研究者
相似试验
未知
3 期
ZO-Y60 Phase III clinical trialGastrointestinal diseaseJPRN-jRCT1080221685ZERIA Pharmaceutical Co.,Ltd.
已完成
3 期
ZO-SA0 PhaseIII clinical trialCardiovascular diseaseJPRN-jRCT1080222354Zeria Pharmaceutical Co., Ltd.60
已完成
2 期
Z-206 Phase III Clinical Trial -Investigation on the remission–maintaining effect in patients with Crohn's disease in remission phasePatients with Crohn's disease in remission phaseJPRN-C000000301Zeria Pharmaceutical Co.,LTD.40
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-C000000300Zeria Pharmaceutical Co.,LTD60
未知
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-jRCT2080220189Zeria Pharmaceutical Co., Ltd.